Among these targets, cathepsin D (CTSD), was implicated as a pivot mediator in adipogenesis, lipid metabolism in mouse hepatic steatosis, mitochondrial dysfunction, cell death, and macrophage infiltration, in hypertrophic adipose tissues of genetically and HFD-induced obese mouse models [150,151]. Here, CTSD is linked to fatty liver disease.